euroPLX 49 Istanbul 2012

More information on euroPLX 49 Istanbul

euroPLX Meetings are the place for pharma deals, attended by industry executives in charge of business development, commercial operations, marketing, and brokers or consultants with clear mandates. euroPLX delivers an average of more than 23 pre-scheduled appointments per participating company.

Partnering scope: Registrants determine the "Dynamic Partnering Focus" of this event. It evolves and changes over time within a range from patented to generic (incl. biosimilars), from prescription to OTC drugs, companion diagnostics, nutraceuticals, and medical devices: development, licensing, marketing, promotion, and distribution. It will be displayed on this page as soon as a sufficient number of collaboration interests are submitted.

In addition, attending companies may offer or look for R&D services, supporting technologies (new drug delivery; medical devices), contract manufacture, and, to some extent, the supply of APIs and intermediates.

More

Registration